Your session is about to expire
← Back to Search
Diagnostic Techniques for Fatty Liver Disease
Study Summary
This trial is assessing the prevalence of two liver diseases, Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and assembling a cohort of adults with these diseases to better understand them.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have never been diagnosed with fatty liver disease.
- Group 1: Subjects at risk for NAFLD
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any recruitment efforts taking place for this experiment?
"Yes, according to clinicaltrials.gov, this medical research is still recruiting participants. It was initially posted on September 29th 2020 and the most recent update was April 14th 2022. Currently 800 patients need to be recruited from one trial site."
What is the current enrollment for this research endeavor?
"Affirmative. Evidence on clinicaltrials.gov states that this experiment is recruiting volunteers, with the initial posting having been made on September 29th 2020 and last edited April 14th 2022. 800 individuals are sought to take part at one medical centre."
Share this study with friends
Copy Link
Messenger